https://www.crpharma.co.in/
CR Pharma | Pharmaceutical API Trader in Mumbai
CR Pharma is a Mumbai based trading and supplying Hub dealing in Pharmaceutical Raw Material. Founded in 2020 by a young Entrepreneur Mr. Chintan Domadia...
cr pharmapharmaceutical apitradermumbai
https://www.business-standard.com/companies/results/strides-pharma-q4-results-posts-net-profit-of-rs-10-44-cr-revenue-up-5-6-124052201111_1.html
Strides Pharma Q4 Results: Posts net profit of Rs 10.44 cr, revenue up 5.6% | Company Results -...
May 22, 2024 - Strides Pharma Q4 Results: In the same quarter of the previous fiscal, Strides reported a loss of Rs 13.79 crore. Ebitda grew 4.61 per cent to Rs 204 crore
https://www.businesstoday.in/latest/corporate/story/glenmark-pharma-to-sell-75-stake-in-glenmark-life-sciences-to-nirma-for-rs-5652-cr-399259-2023-09-21
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr - BusinessToday
Sep 21, 2023 - Glenmark Pharma will own 7.84% in GLS after the divestment; pursuant to the transaction, Nirma Limited will make a mandatory open offer to all public...
https://www.business-standard.com/amp/companies/results/torrent-pharma-q3-results-pat-up-14-at-rs-503-cr-on-strong-india-business-125012401160_1.html
Torrent Pharma Q3 results: PAT up 14% at Rs 503 cr on strong India business | Company Results -...
The revenue grew by 3 per cent Y-o-Y to Rs 2,809 crore as markets like Brazil and the US experienced decline
https://www.business-standard.com/amp/companies/news/piramal-pharma-q3fy25-results-pat-falls-63-to-rs-3-6-cr-revenue-up-12-125012801554_1.html
Piramal Pharma Q3 FY25 results: PAT falls 63% to Rs 3.6 cr, revenue up 12% | Company News -...
Piramal Pharma Q3 Results: Sequentially, revenue from operations declined by 1.67 per cent, with PAT falling 83.7 per cent
https://www.business-standard.com/markets/capital-market-news/ajanta-pharma-pat-jumps-56-yoy-to-rs-210-cr-in-q3-fy24-124020100549_1.html
Ajanta Pharma PAT jumps 56% YoY to Rs 210 cr in Q3 FY24 | Capital Market News - Business Standard
The pharma major's consolidated net profit jumped 56.14% to Rs 210.03 crore in Q3 FY24 as compared with Rs 134.51 crore posted in Q3 FY23.
https://www.deccanherald.com/connect/welcure-drugs-pharma-to-set-up-agro-pharma-lab-for-around-rs-80-cr-3689010
Welcure Drugs & Pharma to set up agro-pharma lab for around Rs 80 cr
https://www.business-standard.com/markets/mutual-fund/icici-pru-phd-fund-direct-g-37119
ICICI Pru P.H.D Fund - Direct (G), Equity - Pharma, ICICI Prudential Mutual Fund, Aum(Rs Cr) - 45.08
ICICI Pru P.H.D Fund - Direct (G): - Find ICICI Pru P.H.D Fund - Direct (G) details, fund class, fund house - ICICI Prudential Mutual Fund, Aum, trailing...
https://www.ceicdata.com/en/sweden/real-deliveries-index-2000100/real-deliveries-index-do-mfg-cr-chemical--chemical-pdts-excl-pharma--medicinal
Sweden Real Deliveries Index: DO: Mfg: CR: Chemical & Chemical Pdts excl Pharma & Medicinal |...
https://www.business-standard.com/amp/industry/news/emcure-arm-tillomed-acquires-manx-pharma-portfolio-for-rs-218-67-cr-125040401004_1.html
Emcure arm Tillomed acquires Manx Pharma portfolio for Rs 218.67 cr | Industry News - Business...
The deal includes the purchase of product dossiers, marketing authorisations, intellectual property, and inventory
https://www.republicworld.com/business/divi-s-labs-bags-global-pharma-deal-plans-rs-700-cr-capacity-boost
Divi's Labs Bags Global Pharma Deal, Plans Rs 700 Cr Capacity Boost | Republic World
Apr 18, 2025 - The pharmaceutical company Divi's Laboratories on Friday said that it has signed a supply agreement with a global pharmaceutical company and is planning a...